Lipidomic approaches identify Parkinson's disease-specific lipid signatures

Serge Przedborski, MD, PhD, Columbia University Irving Medical Center, New York, NY, provides an overview of the ongoing research investigating lipid alterations in Parkinson's disease. Lipidomic approaches have been used to screen a large number of lipids quickly to gain an understanding of the lipid alterations present and potentially find a signature characteristic of Parkinson's disease but not of other conditions. Indeed, lipidomic studies have shown that a number of lipids content are altered in tissue or blood. Future research will focus on understanding the significance of those alterations to the pathophysiology of the disease. This interview took place at the 2022 International Congress of Parkinson's Disease and Movement Disorders in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.